Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
U.K.-based Lucida Medical’s diagnostic tool is already deployed by the NHS, with the company earmarking the funds for the pursuit of regulatory approval in the U.S.
The new agentic program, called “Avery,” is now available to millions of UnitedHealthcare members through its existing app. The insurer said the model will help patients to find providers, understand benefits, get updates on claims and more.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
New findings from a large CT lung cancer screening dataset reveal that a substantial number of patients have significant incidental findings visible on their scans.
In fact, researchers wrote, TAVR and SAVR were linked to comparable long-term outcomes for heart patients who have previously been exposed to mediastinal radiation.
The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.
Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
